Physician profile
Gregorio Caban
NPI 1205894391
$2,435.63
in general payments reported to CMS, 2019-2025
26 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $41.92 · 2021: $217 · 2022: $165 · 2023: $152 · 2024: $745 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985 · Travel and Lodging: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.31 |
| Travel and Lodging | $368.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $555.10 | 2024 | |
| Stryker Corporation | $315.02 | 2019-2025 | Augment Injectable |
| Depuy Synthes Sales INC. | $241.78 | 2019-2023 | Hammerlock |
| Organogenesis INC. | $217.09 | 2022-2025 | Simplimax, Cygnus Dual |
| Horizon Therapeutics Plc | $131.02 | 2019 | |
| Flower Orthopedics Coporation | $115.46 | 2019 | |
| Stimwave Technologies Incorporated | $90.21 | 2019-2022 | |
| Kerecis Limited | $88.54 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Zyla Life Sciences, INC. | $79.78 | 2019-2020 | |
| Smith+Nephew, INC. | $72.00 | 2024-2025 | Collagenase Santyl |
| Embody, INC. | $64.57 | 2021 | |
| Bioventus LLC | $60.29 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Saluda Medical Americas, INC. | $57.50 | 2025 | Evoke |
| Heron Therapeutics, INC. | $45.58 | 2021 | |
| Integra Lifesciences Corporation | $39.88 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $37.89 | 2025 | Novosorb Btm |
| Biotissue Holdings INC. | $29.09 | 2025 | |
| Abbvie INC. | $26.67 | 2021 | |
| Kci USA, INC. | $26.32 | 2020 | |
| Southern Edge Orthopaedics, INC. | $24.18 | 2025 | |
| Treace Medical Concepts, INC. | $21.61 | 2025 | |
| Solventum Corporation | $21.06 | 2024 | Promogran Prisma, Activ.A.C., Kerramax Care |
| Pacira Pharmaceuticals Incorporated | $19.63 | 2025 | Exparel |
| Angiodynamics, INC. | $19.60 | 2019 | |
| Acell, INC. | $19.26 | 2019 | |
| Amniox Medical, INC. | $16.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregorio Caban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.